Table 3
Comparison of indications for penetrating keratoplasty nationally (yearly intervals)* and at the Corneoplastic Unit and Eye Bank (CUEB), 1990–99
| Primary disease nationally (%) | Primary disease at CUEB, 1990–99 (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | Total | Total | ||
| * National data provided by UK Transplant. | |||||||||||||
| †Includes endothelial failure, rejection, primary failure, and other causes of failure. | |||||||||||||
| Regraft† | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.4 | 0.4 | 0.6 | 0.8 | 0.8 | 0.36 | 40.9 | Regraft† |
| Keratoconus | 19 | 20 | 20 | 23 | 26 | 24 | 27 | 26 | 25 | 25 | 23.5 | 15 | Keratoconus |
| Fuchs’ dystrophy | 8 | 8 | 10 | 11 | 10 | 11 | 11 | 13 | 13 | 13 | 10.8 | 9.3 | Fuchs’ dystrophy |
| Endothelial failure: pseudophakic bullous keratopathy | 7 | 10 | 9 | 7 | 7 | 7 | 8 | 7 | 7 | – | 7.6 | 7.6 | Pseudophakic bullous keratopathy |
| Endothelial failure: aphakic bullous keratopathy | 13 | 7 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | – | 4.2 | ||
| Endothelial failure: other | 6 | 4 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | – | 2.5 | ||
| Chronic inflammation: viral keratitis | 6 | 5 | 3 | 4 | 3 | 3 | 3 | 3 | 2 | – | 3.5 | 5.9 | Viral keratitis |
| Chronic inflammation: other | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 1 | 3.2 | |||
| Aetiology uncertain | 3 | 4 | 6 | 5 | 5 | 4 | 3 | 3 | 3 | – | 4 | ||
| Trauma: mechanical | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | – | 1.3 | ||
| Other | 17 | 14 | 10 | 12 | 12 | 37 | 40 | 39 | 42 | 57 | 28 | 17.6 | Other |
| Ocular disease unknown | 13 | 22 | 29 | 30 | 27 | 7 | 1 | 1 | 1 | 3 | 13.4 | ||
| 3.6 | Other dystrophies | ||||||||||||
